Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

被引:18
|
作者
Lee, Joon Kyu [1 ,2 ]
Lee, Kee Byoung [3 ]
Kim, Joong Il [4 ]
Park, Gun Tae [5 ]
Cho, Young Chang [1 ]
机构
[1] Konkuk Univ, Med Ctr, Dept Orthopaed Surg, 120-1 Neungdong Ro, Seoul 05030, South Korea
[2] Konkuk Univ, Sch Med, Res Inst Med Sci, 120-1 Neungdong Ro, Seoul 05030, South Korea
[3] Cheongju St Marys Hosp, Dept Orthopaed Surg, 173-19 Jusung Ro, Cheongju 28323, Chungcheongbuk, South Korea
[4] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Orthopaed Surg, 1 Singil Ro, Seoul 07741, South Korea
[5] Hallym Univ, Dept Orthopaed Surg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea
关键词
Deep vein thrombosis; Total knee arthroplasty; Anticoagulant agent; Low-molecular-weight-heparin; Risk factor; MAJOR ORTHOPEDIC-SURGERY; TOTAL HIP-ARTHROPLASTY; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; GENERAL-ANESTHESIA; ASIAN PATIENTS; THROMBOPROPHYLAXIS; FONDAPARINUX; REPLACEMENT; ENOXAPARIN;
D O I
10.1186/s43019-021-00109-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background With an increase in deep vein thrombosis (DVT) following total knee arthroplasty (TKA) in the Asian population, most surgeons today use a form of prophylactic anticoagulant agents in patients after TKA. Nevertheless, DVT occasionally develops even in these patients with prophylaxis. The purpose of this study was to identify the risk factors for DVT after TKA in cases of postoperative low-molecular-weight heparin (LMWH) use. Methods We designed a retrospective study with 103 patients who underwent primary TKA. From the second postoperative day, 60 mg of LMWH was subcutaneously injected into the patients daily. On the seventh postoperative day, patients had computed tomography angiography to check whether they had DVT. Regarding risk factors, we investigated patients' gender, age, surgical site (unilateral/bilateral), body mass index, method of anesthesia, preoperative hypertension, diabetes, hypercholesterolemia status, and prothrombin time/international normalized ratio from electronic medical records. We analyzed the statistical significance of these risk factors. Results Statistically significant factors in the single-variable analysis were surgical site (unilateral/bilateral), body mass index, preoperative hypertension status, and anesthesia method. Multiple logistic regression analysis with these factors revealed that the surgical site (unilateral/bilateral, p = 0.024) and anesthesia method (p = 0.039) were significant factors for the occurrence of postoperative DVT after TKA. Conclusions Patients undergoing simultaneous bilateral TKAs and patients undergoing TKA with general anesthesia need more attention regarding DVT even with chemoprophylaxis using LMWH after TKA.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (04) : 225 - 239
  • [42] PREVENTION OF DEEP-VEIN THROMBOSIS BY LOW-MOLECULAR-WEIGHT HEPARIN AND DIHYDROERGOTAMINE IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT
    FREICK, H
    HAAS, S
    THROMBOSIS RESEARCH, 1991, 63 (01) : 133 - 143
  • [43] Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH)
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (03) : 150 - 170
  • [44] Release of the tourniquet immediately after the implantation of the components reduces the incidence of deep vein thrombosis after primary total knee arthroplasty
    Zan, P.
    Mol, M. O.
    Yao, J. J.
    Fan, L.
    Yang, D.
    Liu, K.
    Li, G.
    BONE & JOINT RESEARCH, 2017, 6 (09): : 535 - 541
  • [45] The risk factor of preoperative deep vein thrombosis in patients undergoing total knee arthroplasty
    Wakabayashi, Hiroki
    Hasegawa, Masahiro
    Niimi, Rui
    Yamaguchi, Toshio
    Naito, Yohei
    Sudo, Akihiro
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2017, 22 (04) : 698 - 702
  • [46] Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery
    De, Anushtup
    Roy, Prabal
    Garg, Vinod K.
    Pandey, Narendra K.
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 57 - 61
  • [47] Can all patients with deep vein thrombosis receive low-molecular-weight heparin in an outpatient setting?
    Lindmarker, P
    HAEMOSTASIS, 1999, 29 : 84 - 88
  • [48] Outpatient therapy with low-molecular-weight heparins:: New perspectives for treatment of deep vein thrombosis
    Büller, HR
    HAEMOSTASIS, 1998, 28 : 91 - 94
  • [49] A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis
    Wang, Lin
    Xu, Zhujun
    Zhang, Lin
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2024, 24 (02) : 185 - 191
  • [50] Risk factors for deep vein thrombosis of the lower extremity after total hip arthroplasty
    Hang, Lin
    Haibier, Abuduwupuer
    Kayierhan, Aiben
    Abudurexiti, Tuerhongjiang
    BMC SURGERY, 2024, 24 (01)